LATEST

Off the Wire

IN FOCUS

Omega-3 Fatty Acid and Breast Cancer Prevention for Patients Hoping for Pregnancy

A pilot trial at the National Cancer Institute, conducted by the University of Kansas Cancer Center and led by Principal Investigator Lauren Nye aims to explore the...

Turning Cancer’s Acidity Against Itself Without Harming Healthy Tissue

A team of researchers from Vanderbilt University and Vanderbilt University Medical Center has developed a groundbreaking method to destroy tumors by disrupting their acidic environment, which is...

Second Chances at a Price: The High Stakes of Reoperation in Breast Cancer

A recent study published in the Annals of Surgical Oncology, has brought attention to a concerning trend in the treatment of breast cancer, specifically regarding breast-conserving surgery....

LEARN MORE

RESEARCH

RESEARCH

LEARN MORE

Olaparib Study Cites Manageable Side Effects, No Lasting Quality of Life Impact

A recent clinical trial investigated olaparib's effects on patients with HER2-negative, BRCA-mutated early breast cancer, focusing on fatigue. Results showed temporary tiredness and nausea...

Kintara Therapeutics Initiates Trial for Breast Cancer Treatment with REM-001

Kintara Therapeutics has started a clinical trial to study REM-001, targeting patients with cutaneous metastatic breast cancer (CMBC). This trial, which is open to...

What a Massive Study of 12 Million Says About Breast Cancer Screening, Rates

A recent study, remarkable for its sheer sample size, sheds light on the escalating issue of breast cancer among women in China, highlighting a...

A New AI Tool to Sharpen Breast Cancer Diagnosis Using Ultrasound Images

Imagine you're trying to tell apart three very similar-looking leaves to figure out which one might be from a plant that's not healthy, but...

Breast Cancer Survivors Have Unique Metabolic Needs: Implications for Nutrition

A recent study from the University of Antwerp in Belgium has revealed that breast cancer survivors have higher metabolic rates relative to muscle mass...

DRUG DEVELOPMENT